Effect of Spirulina in the treatment of Diabetes
Phase 2
- Conditions
- Diabetes type2.E11
- Registration Number
- IRCT2016052528067N1
- Lead Sponsor
- Vice Chancellor for research of Ferdowsi University of Mashhad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The age range of 30-60 years old; Type II Diabetic patients ; Disease duration 5-10 years ; Fasting blood glucose 126-300 milligram per deciliter ; Hemoglobin A1c more than 7
Exclusion criteria:
Smoking; Develop other underlying medical condition ; Pregnancy and Breastfeeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma glucose. Timepoint: 0 and 30 days and 60 days and 90 days after intervention. Method of measurement: milligrams per deciliter by Autoanalyser.;Hemoglubin A1c. Timepoint: At 0 and 90 days after intervention. Method of measurement: milligrams per deciliter by NycoCard.
- Secondary Outcome Measures
Name Time Method iver function tests. Timepoint: every 3 month. Method of measurement: Auto analyzer kits.